EU transparency in the development, purchase and distribution of COVID-19 vaccines

Reference B9-0519/2021Health

The short versionAI

A plain-language explanation, ready in a few seconds.

Summary written by AI from the official roll-call record. It can make mistakes, so check the numbers.

How the groups voted

GroupForAgainstAbstainedAbsentUnity

The Left39

3530192%

S&D146

13803598%

Greens/EFA73

730

The European Parliament adopted by 458 votes to 149, with 86 abstentions, a resolution on EU transparency in the development, purchase and distribution of COVID-19 vaccines.The resolution underlined that the handling of the COVID-19 pandemic is a trust test for all Member States and EU institutions that will inform the response to possible future public health emergencies. Full transparency regarding all details of research into and the development, purchase and distribution of COVID-19 vaccines is the fundamental prerequisite for enhancing citizens’ trust in vaccines and the way in which institutions have spent huge amounts of public funds.The Commission and the Member States are obliged to work as openly as possible and as closely as…